Role of a C-Terminal Residue of an Immunodominant Epitopein T Cell Activation and Repertoire Diversity

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 127-135

  Mikszta, John A ^a   Jang, Yong Suk ^a,b   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; LYSOZYME; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C3H MOUSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HYBRIDOMA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; MOUSE; PROTEIN CONFORMATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; FEMALE; HYBRIDOMAS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; MURAMIDASE; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0030636559     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
2. Rothbard, J. B., and M. L. Gefter. 1991. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9:527.
3. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
4. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
5. Chicz, R. M., R. G. Urban, W. S. Lane, J. C. Gorga, L. J. Stern, D. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
6. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261.
7. Rudensky, A., P. Preston-Hurlburt, B. K. al-Ramadi, J. Rothbard, and C. A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429.
8. Matsumura, M., D. H. Fremont, P. A. Peterson, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
9. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
10. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
11. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
12. Allien, P. M., G. R. Matsueda, R. J. Evans, J. B. Dunbar, Jr., G. R. Marshall, and E. R. Unanue. 1987. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327:713.
13. Sette, A., S. Buus, S. Colon, J. A. Smith, C. Miles, and H. M. Grey. 1987. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328:395.
14. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J. Exp. Med. 168: 2045.
15. Lorenz, R. G., A. N. Tyler, and P. M. Allen. 1989. Reconstruction of the immunogenic peptide RNase(43-56) by identification and transfer of the critical residues into an unrelated peptide backbone. J. Exp. Med. 170:203.
16. Evavold, B. D., S. G. Williams, B. L. Hsu, S. Buus, and P. M. Allen. 1992. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 148:347.
17. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define lhe requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
18. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13.
19. Rolzschke, O., and K. Falk. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6:45.
20. Sinigaglia, F., and J. Hammer. 1994. Defining rules for the peptide-MHC class II interaction. Curr. Opin. Immunol. 6:52.
21. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
22. Evavold, B. D., S. G. Williams, J. S. Chen, and P. M. Allen. 1991. T cell inducing determinants contain a hierarchy of residues contacting the T cell receptor. Semin. Immunol. 3:225.
23. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.
24. Allen, P. M., D. J. Strydom, and E. R. Unanue. 1984. Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc. Natl. Acad. Sci. USA 81:2489.
25. k molecule. J. Immunol. 135:368.
26. Adorini, L., E. Appella, G. Doria, and Z. A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinant. J. Exp. Med. 168:2091.
27. Gammon, G., H. M. Geysen, R. J. Apple, E. Pickett, M. Palmer, A. Ametani, and E. E. Sercarz. 1991. T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J. Exp. Med. 173:609.
28. Kim, B. S., and Y. S. Jang. 1992. Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice. Eur. J. Immunool. 22:775.
29. Jang, Y. S., J. A. Mikszta, and B. S. Kim. 1994. T cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice. Mol. Immunol. 31:803.
30. Grewal, I. S., K. D. Moudgil, and E. E. Sercarz. 1995. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. Proc. Natl. Acad. Sci. USA 92:1779.
31. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90:1227.
32. k. J. Immunol. 157:755.
33. Inoue, A., Y. K. Choe, and B. S. Kim. 1994. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 68:3324.
34. Sharrock, C. E., E. Kaminski, and S. Man. 1990. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol. Today 11:281.
35. Burleson, J. A., T. A. Binder, and I. Goldschneider. 1993. Use of logistic regression in comparing multiple limiting dilution analyses of antigen-reactive T cells. J. Immunol. Methods 159:47.
36. Hathcock, K. S. 1992. T cell enrichment by nonadherence to nylon. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. N. Kruisbeek, D. H. Marguiles, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 3.2.
37. Shastri, N., A. Oki, A. Miller, and E. E. Sercarz. 1985. Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins: implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects. J. Exp. Med. 162:332.
38. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
39. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. C. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
40. Jameson, S. C., and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1.
41. Alexander, J., K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F. C. Gaeta, S. M. Colon, H. M. Orey, and A. Sette. 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150:1.
42. Baumhuter, S., C. J. Wallace, A. E. Proudfoot, C. Bron, and G. Corradin. 1987. Multiple T cell antigenic determinants identified within a limited region of the horse cytochrome c molecule. Eur. J. Immunol. 17:651.
43. Bhayani, H., and Y. Paterson. 1989. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations. J. Exp. Med. 170:1609.
44. Haberman, A. M., C. Moller, D. McCreedy, and W. U. Gerhard. 1990. A large degree of functional diversity exists among helper T cells specific for the same antigenic site of influenza hemagglutinin. J. Immunol. 145:3087.
45. Kurata, A., and J. A. Berzofsky. 1990. Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule? J. Immunol. 144:4526.
46. Wiertz, E., J. van Gaans-van den Brink, P. Hoogerhout, and J. Poolman. 1993. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein. Eur. J. Immunol. 23:232.
47. d. J. Immunol. 155:2849.
48. Harris, D. P., H. M. Vordermeier, A. Arya, C. Moreno, and J. Ivanyi. 1995. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules. Immunology 84:555.
49. Mikszta, J. A., and B. S. Kim. 1996. Conversion of low antibody responders into high responders by upregulating the T cell response to a selective epitope. J. Immunol. 157:2883.
50. k-restricted T helper hybridomas. J. Immunol. 142:3298.
51. Sant' Angelo, D. B., G. Waterbury, P. Preston-Hurlburt, S. T. Yoon, R. Medzhitov, S.-C. Hong, and C. A. Janeway, Jr. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4:367.
52. Moudgil, K. D., I. S. Grewal, P. E. Jensen, and E. E. Sercarz. 1996. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J. Exp. Med. 183:535.
53. Viner, N. J., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156:2365.
54. k. Proc. Natl. Acad. Sci. USA 89:7380.
55. Vignali, D. A., R. G. Urban, R. M. Chicz, and J L. Strominger. 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1602.
56. Jorgensen, J. L., U. Esser, B. F. de St. Groth, P. A. Reay, and M. M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224.
57. Wedderbum, L. R., S. J. Searle, A. R. Rees, J. R. Lamb, and M. J. Owen. 1995. Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide. Eur. J. Immunol. 25:1654.
58. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
59. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
60. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1994. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc. Natl. Acad. Sci. USA 91:2300.
61. Vidal, K., B. L. Hsu, C. B. Williams, and P. M. Allen. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311.
62. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
63. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
64. Mannie, M. D., J. M. Rosser, and G. A. White. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4, evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154:2642.
65. Jameson, S. C., K. A. Hogquist, and M. J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature 369:750.